# RFA for Flat Type High-grade and Medium-grade Intraepithelial Squamous Neoplasia

> **NCT02953418** · NA · TERMINATED · sponsor: **Medtronic - MITG** · enrollment: 34 (actual)

## Conditions studied

- Esophageal Squamous Cell Neoplasia (ESCN)

## Interventions

- **DEVICE:** Radiofrequency ablation

## Key facts

- **NCT ID:** NCT02953418
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-20
- **Primary completion:** 2019-07-20
- **Final completion:** 2019-07-20
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Enrollment taking longer than expected.
- **Last updated:** 2020-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02953418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02953418, "RFA for Flat Type High-grade and Medium-grade Intraepithelial Squamous Neoplasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02953418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*